Water-Soluble Ruthenium(II) p -Cymene Complexes Mitigating Intracellular S. aureus Infection: Bridging Antibacterial Défense and Anticancer Therapy
Journal of Medicinal Chemistry · 28.08.2025 · 68 (16) · 17897-17916
DOI: 10.1021/acs.jmedchem.5c01643 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 13.08.2025. Verfasst von Himanshu Sonker und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Indian Institute of Technology, Kanpur, 208016 UP, India. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Ruthenium, Antineoplastic Agents, Staphylococcus aureus. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Indian Council of Medical Research, Council of Scientific and Industrial Research, India, Science and Engineering Research Board.
Abstract (Originalsprache)
The global rise of antimicrobial resistance and aggressive cancers like triple-negative breast cancer (TNBC) demands dual-functional therapies. We synthesized water-soluble ruthenium(II) p-cymene complexes (RuL1–RuL5) using quinoxaline–pyridyl ligands with strategic C6-substitutions. Structure–activity relationship studies identified halogenated RuL1 (−Br) as the most potent, showing selective activity against Gram-positive bacteria (MIC = 8 μg/mL vs Staphylococcus aureus). Mechanistic studies revealed membrane-targeted antibacterial action, supported by AFM, SEM, and fluorescence assays showing disruption, depolarization, and biofilm inhibition. RuL1 was also effective against intracellular S. aureus in HeLa cells, with good hemocompatibility and in vivo efficacy in a murine abscess model. Additionally, RuL1 exhibited strong anticancer activity against MDA-MB-231 TNBC cells (IC50 = ∼2.38 μM), while sparing HEK-293 cells. Mechanistic assays confirmed mitochondrial depolarization, ROS generation, and inhibition of migration and clonal expansion. These results position RuL1 as a promising dual-action metallotherapeutic for combating both drug-resistant bacteria and TNBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Indian Institute of Technology, Kanpur, 208016 UP, India.
ORCID-Profile: Ritika Gautam Singh
Förderung
- Indian Council of Medical Research
- Council of Scientific and Industrial Research, India
- Science and Engineering Research Board
- Department of Science and Technology, Ministry of Science and Technology, India
Zitieren
APA
Sonker, H., Dewan, S., Chaudhary, K., Agrahari, B., Rathore, N., Jain, P., & Singh, R. G. (2025). Water-Soluble Ruthenium(II) p -Cymene Complexes Mitigating Intracellular S. aureus Infection: Bridging Antibacterial Défense and Anticancer Therapy. Journal of Medicinal Chemistry, 68(16), 17897-17916. https://doi.org/10.1021/acs.jmedchem.5c01643
Vancouver
Sonker H, Dewan S, Chaudhary K, Agrahari B, Rathore N, Jain P, et al. Water-Soluble Ruthenium(II) p -Cymene Complexes Mitigating Intracellular S. aureus Infection: Bridging Antibacterial Défense and Anticancer Therapy. Journal of Medicinal Chemistry. 2025;68(16):17897-17916. doi:10.1021/acs.jmedchem.5c01643
BibTeX
@article{Sonker2025,
author = {Sonker, Himanshu and Dewan, Sayari and Chaudhary, Kajal and Agrahari, Bhumika and Rathore, Neelam and Jain, Pranshu and Singh, Ritika Gautam},
title = {Water-Soluble Ruthenium(II) p -Cymene Complexes Mitigating Intracellular S. aureus Infection: Bridging Antibacterial Défense and Anticancer Therapy},
journal = {Journal of Medicinal Chemistry},
year = {2025},
volume = {68},
number = {16},
pages = {17897--17916},
doi = {10.1021/acs.jmedchem.5c01643}
}
EUVIMED